US FDA withdraws OTC analgesic labelling rule
This article was originally published in Scrip
Executive Summary
The US FDA's quick withdrawal of a final rule requiring organ-specific warnings for over-the-counter analgesics has prompted speculation that the new Obama Administration is scrutinising pre-emption language in the regulation.